Using Minimal Residual Disease for DLBCL Response Assessment

(MedPage Today) — Ahead of the upcoming American Society of Hematology annual meeting, a multicenter study published in the Journal of Clinical Oncology is reshaping expectations around how clinicians may soon evaluate treatment response in diffuse…